SCHEMBL17593276

SCHEMBL17593276

Cn1c(C(=O)Nc2ccc(S(=O)(=O)Nc3ncccn3)cc2)cc2cc(Cl)ccc21

nearest known ligand 0.65

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ RXFP1 Q9HBX9 2/20 0.65
▸ MAPT P10636 2/20 0.60
▸ TP53 P04637 2/20 0.60
▸ KMT2A Q03164 7/20 0.58
▸ MEN1 O00255 5/20 0.58
▸ KDM4E B2RXH2 5/20 0.58
▸ TDP1 Q9NUW8 1/20 0.55
▸ ALDH1A1 P00352 3/20 0.54
▸ POLB P06746 2/20 0.54
▸ ROCK1 Q13464 1/20 0.53
▸ L3MBTL1 Q9Y468 1/20 0.53
▸ THRB P10828 1/20 0.52
▸ HTT P42858 1/20 0.51
▸ HPGD P15428 1/20 0.51
▸ MAPK1 P28482 1/20 0.51
▸ SMN1; SMN2 Q16637 1/20 0.51
▸ NPSR1 Q6W5P4 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17593216 0.88 L3MBTL1 (0.57) RXFP1MAPTTP53KMT2AMEN1
SCHEMBL19332444 0.87 TDP1 (0.58) RXFP1MAPTTP53KMT2AMEN1
SCHEMBL19332231 0.86 TP53 (0.54) RXFP1MAPTTP53KMT2AMEN1
SCHEMBL19332449 0.85 L3MBTL1 (0.54) RXFP1MAPTTP53KMT2AMEN1
SCHEMBL15113299 0.85 AVPR2 (0.65) RXFP1MAPTKMT2AMEN1KDM4E
SCHEMBL19345938 0.84 MAPT (0.55) RXFP1MAPTTP53KMT2AMEN1
SCHEMBL19332216 0.83 MAPT (0.57) RXFP1MAPTTP53KMT2AMEN1
SCHEMBL19332443 0.83 TDP1 (0.56) RXFP1MAPTTP53KMT2AMEN1
SCHEMBL19332597 0.83 MAPT (0.54) RXFP1MAPTTP53KMT2AMEN1
SCHEMBL19346220 0.83 MAPT (0.56) MAPTTP53KMT2AMEN1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016040449-A1 3-PHOSPHOGLYCERATE DEHYDROGENASE INHIBITORS AND USES THEREOF RAZE THERAPEUTICS, INC. (US) 2016-03-17 — — WO disclosed
Send feedback